How Eisai (TSE:4523) Is Reframing Its Story With A Tweaked Fair Value Outlook
Arcus Biosciences Inc RCUS
$24.40
β² +1.79%
(+$0.43)
Open
$23.88
Prev Close
$23.97
Day Range
$23.48 β $24.53
52W Range
$7.91 β $28.72
Market Cap
$2.97B
Beta
0.83
EPS (TTM)
$-3.18
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2018-03-15 |
| Shares Out. | 125,770,000 |
| Website | arcusbio.com/ β |
| Phone | 15106946200 |
Arcus Biosciences Inc is a publicly traded company under the ticker symbol RCUS on the NEW YORK STOCK EXCHANGE, INC., operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
18 analysts (2026-05-01)
